Markets:

Overview

News

Currencies

International

Treasuries

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

300.18 -0.50 (-0.17%)

Official Closing Price Updated: 4:00 PM EDT, May 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stocks That Hit 52-Week Lows On Tuesday ↗

September 27, 2022

On Tuesday, 456 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

September 19, 2022

On Monday, 429 stocks made new 52-week lows.

Via Benzinga

West Pharmaceutical Services Shares Slides Post Q1 Results ↗

April 28, 2022

Via Benzinga

Here's How Much $1000 Invested In West Pharmaceutical Servs 10 Years Ago Would Be Worth Today ↗

August 05, 2022

West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 10 years by 18.96% on an annualized basis producing an average annual return of 30.3%. Currently, West Pharmaceutical...

Via Benzinga

West Pharmaceutical Servs's Return On Capital Employed Insights ↗

August 03, 2022

According to Benzinga Pro, during Q2, West Pharmaceutical Servs (NYSE:WST) earned $188.50 million, a 8.46% increase from the preceding quarter. West Pharmaceutical Servs also posted a total of $771.30...

Via Benzinga

West Pharmaceutical Services: Q2 Earnings Insights ↗

July 28, 2022

West Pharmaceutical Servs (NYSE:WST) reported its Q2 earnings results on Thursday, July 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

West Pharmaceutical Servs: Q1 Earnings Insights ↗

April 28, 2022

West Pharmaceutical Servs (NYSE:WST) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Becton Dickinson Stock Near High, Hits 80-Plus RS Rating ↗

April 26, 2022

Becton Dickinson stock shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 82.

Via Investor's Business Daily

19 Dividend Stocks That Pay In February, May, August And November ↗

April 22, 2022

Looking to fill in your dividend calendar? These top dividend stocks pay quarterly.

Via Talk Markets

Earnings Scheduled For February 17, 2022 ↗

February 17, 2022

Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million.

Via Benzinga

Earnings Scheduled For October 28, 2021 ↗

October 28, 2021

Companies Reporting Before The Bell • LendingTree (NASDAQ:TREE) is estimated to report quarterly earnings at $0.57 per share on revenue of $292.63 million. •...

Via Benzinga

Earnings Scheduled For July 28, 2022 ↗

July 28, 2022

Companies Reporting Before The Bell • ArcelorMittal (NYSE:MT) is estimated to report earnings for its second quarter.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 04, 2022

During Wednesday's trading, 435 companies set new 52-week lows.

Via Benzinga

Earnings Scheduled For April 28, 2022 ↗

April 28, 2022

Companies Reporting Before The Bell • PBF Energy (NYSE:PBF) is projected to report quarterly earnings at $0.26 per share on revenue of $8.24 billion.

Via Benzinga

7 Healthcare Stocks to Buy for the Long Term ↗

March 21, 2022

When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks.

Via InvestorPlace

Ominous Death Cross Forms On West Pharmaceutical Servs's Chart ↗

February 28, 2022

If history is any guide, there may be trouble ahead for shares of West Pharmaceutical Servs (NYSE:WST). A so-called "death cross" has formed on its chart and, not surprisingly,...

Via Benzinga

The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios ↗

February 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel...

Via Benzinga

West Pharmaceutical's Q4 Performance Surpass Expectations, Expects FY22 Sales To Increase 8% ↗

February 17, 2022

West Pharmaceutical Services Inc's (NYSE: WST) Q4 net s

Via Benzinga

West Pharmaceutical Servs: Q4 Earnings Insights ↗

February 17, 2022

West Pharmaceutical Servs (NYSE:WST) reported its Q4 earnings results on Thursday, February 17, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More ↗

February 13, 2022

Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news...

Via Benzinga

26 Firms Going Ex-Dividend Next Week, Including CVS Health, APA Corp. And Procter & Gamble ↗

January 14, 2022

There are several well known large cap stocks going ex-dividend next week including 4 of our Top 100 Dividend Stocks.

Via Talk Markets

West Pharmaceutical Servs's Ex-Dividend Date Is Monday, Here's What You Need To Know ↗

January 13, 2022

Monday marks the last chance for investors to receive the next dividend payout from West Pharmaceutical Servs. What's Happening

Via Benzinga

Microsoft, Google Lead 5 Long-Term Leaders Near Buy Points ↗

December 24, 2021

Microsoft has formed a flat base amid solid growth. Google is actionable now.

Via Investor's Business Daily

$1000 Invested In This Stock Over The Last 15 Years, Would Be Worth This Much ↗

November 17, 2021

West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 15 years by 12.76% on an annualized basis. Buying $1,000 In WST: 15 years ago, an investor could...

Via Benzinga

Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 15 Years ↗

November 09, 2021

West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 15 years by 12.12% on an annualized basis. Buying $1,000 In WST: 15 years ago, an investor could...

Via Benzinga

When Winning Streaks Stop: Trying To Beat The Market By Buying Stocks Like Tesla ↗

November 08, 2021

Teslas getting charged in a Wawa parking lot last month. Photo via author. When Winning Streaks Stop In a post in August (Tesla And The Quest For Alpha), we wrote about how a...

Via Benzinga

When Winning Streaks Stop ↗

November 07, 2021

Trying to beat the market by buying stocks like Tesla. It's probably impossible to time these things perfectly, but as we continue to collect data, we may be able to spend more time in winning...

Via Talk Markets

West Pharmaceutical Services (WST) Q3 2021 Earnings Call Transcript ↗

October 28, 2021

WST earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

West Pharmaceutical Services: Q3 Earnings Insights ↗

October 28, 2021

West Pharmaceutical Servs (NYSE:WST) reported its Q3 earnings results on Thursday, October 28, 2021 at 06:00 AM. Here's what investors need to know about the...

Via Benzinga

West Pharmaceutical Servs's Earnings: A Preview ↗

October 27, 2021

West Pharmaceutical Servs (NYSE:WST) is set to give its latest quarterly earnings report on Thursday, 2021-10-28. Here's what investors need to know before the announcement....

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.